Scorpius Holdings Announces Strategic Update Amid Rising CDMO Demand, Eyes Expansion into Southeast Asia

Scorpius Holdings, Inc. (OTC: SCPX), a biomanufacturing company dedicated to advancing therapeutic production capabilities, today announced a comprehensi...

May 05, 2025 | Monday | News
Crown Bioscience Extends Exclusive Partnership with NEXT Oncology to Advance Translational Cancer Research

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corp...

May 02, 2025 | Friday | News
PCI Pharma Services Acquires Ajinomoto Althea to Expand Global Sterile Fill-Finish and ADC Capabilities

Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery...

May 02, 2025 | Friday | News
Kytopen and Aldevron Partner to Streamline CRISPR T-Cell Engineering with Breakthrough Non-Viral Workflow

Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organ...

May 01, 2025 | Thursday | News
Innovent Biologics Doses First Patient in Global Phase 1 Trial of IBI3020, First-in-Class Dual-Payload CEACAM5 ADC

Innovent Biologics, Inc. ("Innovent"), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for t...

May 01, 2025 | Thursday | News
Asimov and Cytiva Partner to Offer End-to-End Biologics Production Platform for Complex Modalities

    Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell line developme...

April 30, 2025 | Wednesday | News
Rising IgA Nephropathy Cases Drive Demand for Innovative Treatments as Targeted Therapies Gain Ground

IgA nephropathy (IgAN) is an autoimmune disorder that affects the kidneys by impairing the filtration function of the small blood vessels. It is caused by ...

April 29, 2025 | Tuesday | News
Accent Therapeutics Unveils Promising Preclinical Data on First-in-Class Cancer Therapeutics ATX-559 and ATX-295 at AACR 2025

 Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer therapeutics, announced new preclin...

April 29, 2025 | Tuesday | News
Merck Makes $3.9 Billion Bet on Rare Tumors With SpringWorks Therapeutics Acquisition

  Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $...

April 29, 2025 | Tuesday | News
Pfizer’s Sasanlimab Plus BCG Significantly Extends Event-Free Survival in High-Risk NMIBC Patients in Phase 3 Trial

Pfizer Inc. announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination wi...

April 28, 2025 | Monday | News
MDDAP Launches New Certification Pathway to Empower MedTech Professionals

MDDAP is empowering professionals with new opportunities to excel in the medical device sector through a cutting-edge learning pathway designed for the Vol...

April 25, 2025 | Friday | News
Vector BioMed COO Mike Kadan on Reinventing Viral Vector Manufacturing for a Decentralized Gene Therapy Future

In this exclusive interview with BioPharma BoardRoom, Mike Kadan, PhD, MBA, Chief Operating Officer of Vector BioMed, shares how the company is reimagining...

April 25, 2025 | Friday | Interview
Adcentrx Therapeutics to Present First Clinical Data for ADC Candidate ADRX-0706 at 2025 ASCO Annual Meeting

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and...

April 24, 2025 | Thursday | News
Antengene to Present Promising Clinical Data on ATG-037 and ATG-008 at 2025 ASCO Annual Meeting

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commer...

April 24, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close